Marked QTc prolongation and Torsades de Pointes in patients with chronic inflammatory arthritis

Marked QTc prolongation and Torsades de Pointes in patients with chronic inflammatory arthritis

Mounting evidence indicates that in chronic inflammatory arthritis (CIA), QTc prolongation is frequent and correlates with systemic inflammatory activation. Notably, basic studies demonstrated that inflammatory cytokines induce profound changes in potassium and calcium channels resulting in a prolon...

Full description

Bibliographic Details
Main Authors:	Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Iacopo Bertolozzi, Gabriella Morozzi, Sauro Lorenzini, Antonella Simpatico, Selvi Enrico, Maria Romana Bacarelli, Maurizio Acampa, Deana Lazaro, Nabil El-Sherif, Mohamed Boutjdir, Franco Laghi-Pasini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-09-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	Interleukin-6 Torsades de Pointes sudden death systemic inflammation Chronic inflammatory arthritis
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fcvm.2016.00031/full

Similar Items

Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes
by: Pietro Enea Lazzerini, et al.
Published: (2020-05-01)

Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men
by: Pietro Enea Lazzerini, et al.
Published: (2022-01-01)

Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome
by: Pietro Enea Lazzerini, et al.
Published: (2021-09-01)

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes
by: Pietro E. Lazzerini, et al.
Published: (2018-04-01)

Ondansetron induced torsades de pointes
by: Eshan Patel, et al.
Published: (2019-08-01)

Risk of QTc Interval Prolongation Associated With Circulating Anti‐Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study
by: Pietro Enea Lazzerini, et al.
Published: (2021-02-01)

Nearly Fatal Torsade de Pointes with Sotalol
by: Bernhard Strohmer, et al.
Published: (2003-10-01)

Methadone-induced Torsade de pointes tachycardias
by: Swiss Medical Weekly
Published: (2005-05-01)

Voltage/Calcium Uncoupling Underlies Sustained Torsade de Pointes Ventricular Tachyarrhythmia in an Experimental Model of Long QT Syndrome
by: Herman D. Himel, et al.
Published: (2021-01-01)

Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes
by: Karthik Gnanapandithan, et al.
Published: (2021-02-01)

Commentary: Systemic effects of IL-17 in inflammatory arthritis
by: Pietro Enea Lazzerini, et al.
Published: (2019-12-01)

Torsades de Pointes
by: Richard J Chen, MD, et al.
Published: (2018-04-01)

KINEMATICAL PARTICULARITIES IN PROCESSING THE CONSTANT AND VARIABLE LAY-UP TORSADES
by: Ivan CISMARU
Published: (2016-11-01)

Elevated Interleukin‐6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans
by: Pietro Enea Lazzerini, et al.
Published: (2024-02-01)

Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies
by: Pietro Enea Lazzerini, et al.
Published: (2018-11-01)

Síndrome do QT longo e torsades de pointes pós-parto Síndrome de QT largo y torsades de pointes postparto Postpartum torsades de pointes and long QT syndrome
by: Alexandre Maulaz Barcelos, et al.
Published: (2009-10-01)

A Case of Ciprofloxacin-Induced QT Prolongation and Torsade de Pointes
by: Hedieh Keshavarz-Bahaghighat, et al.
Published: (2017-09-01)

Incidence of drug-induced torsades de pointes with intravenous amiodarone
by: Jayaprakash Shenthar, et al.
Published: (2017-11-01)

Torsade de Pointes Following Myocarditis; A Case Report
by: Kayıhan Karaman, et al.
Published: (2019-06-01)

Risperidone alone did not induce torsade de pointes: Experimental evidence from the chronic atrioventricular block model dogs
by: Yoshio Nunoi, et al.
Published: (2020-08-01)

Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
by: Anunay Gupta, et al.
Published: (2020-09-01)

Intravenous anti-influenza drug oseltamivir will not induce torsade de pointes: Evidences from proarrhythmia model and action-potential assay
by: Yuji Nakamura, et al.
Published: (2016-05-01)

Atrioventricular block and pause-dependent torsade de pointes
by: Mustafa Dohadwala, MD, et al.
Published: (2017-02-01)

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
by: Irina Nordkin, et al.
Published: (2021-01-01)

Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion
by: Ken Shimano, et al.
Published: (2021-10-01)

A case of hypoglycemiainduced QT prolongation leading to torsade de pointes and a review of pathophysiological mechanisms
by: Faris Hannoodi, et al.
Published: (2017-06-01)

Prevention of Torsade de Pointes during the Pharmacologic Treatment of Atrial Fibrillation
by: Hideo Mitamura, MD, PhD
Published: (2010-01-01)

A rare case of myotonic dystrophy type 1 presenting with Torsades de pointes
by: Amit Handa, et al.
Published: (2023-01-01)

Rare case of Torsades de Pointes in severe hypothyroidism: literature review and challenges in management
by: Berlin Lee, et al.
Published: (2022-03-01)

Case report: Ivabradine induced Torsades de Pointes
by: Mohit M. Bhagwati, et al.
Published: (2023-01-01)

Torsades de pointes following vaccination for COVID-19
by: Victor A. Abrich, MD, FHRS, et al.
Published: (2022-06-01)

Methadone induced torsades de pointes and ventricular fibrillation: A case review
by: Somayeh Khalesi, et al.
Published: (2014-11-01)

Dofetilide induced torsade de pointes: Mechanism, risk factors and management strategies
by: Abhishek Jaiswal, et al.
Published: (2014-11-01)

Prolonged ST segment and T‐wave alternans with torsade de pointes secondary to hypocalcemia due to hypoparathyroidism: A case report
by: Jiang Liu, et al.
Published: (2022-07-01)

Occurrence of Torsade de Pointes prior to complete lead connection during pacemaker implantation
by: Yusuke Morita, et al.
Published: (2022-09-01)

Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry
by: Francesca Girolami, et al.
Published: (2022-12-01)

Mechanisms of torsades de pointes: an update
by: Yukiomi Tsuji, et al.
Published: (2024-03-01)

A hosszú-QT-szindróma és a torsades de pointes kamrai tachycardia története Historical overview of long-QT syndrome and torsades de pointes ventricular tachycardia
by: Fazekas Tamás, Prof. Dr
Published: (2012-12-01)

PONV management in patients with QTc prolongation on the EKG
by: S. Soghomonyan, et al.
Published: (2021-01-01)

Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose
by: Jan Albert Nicolaas Groot, et al.
Published: (2018-09-01)